Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

A study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence ...

This efficient platform is anticipated to significantly contribute to the development of personalized cancer treatments. Professor Charles Lee from The Jackson Laboratory for Genomic Medicine ...

A collaborative research team from POSTECH has successfully developed a gastric cancer model using 3D bioprinting technology ...

There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

A dad who has battled four brain tumors – discovering one after developing a craving for olives – is raising $50,000 for ...

A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...